U.S. Markets close in 7 mins

AbbVie's $63 billion Allergan deal shakes up big pharma

The healthcare industry is going through a transformation after a wave of recent deals including AbbVie's $63 billion deal to buy Botox maker Allergan. Yahoo Finance's Alexis Christoforous and Brian Sozzi speak to Chris Meekins, Raymond James Healthcare Policy analyst.